Trial design
migraine, ICHD-3
MIGRAINE, HEADACHE DISORDERS
The trial conducted was a double-blind, randomized, placebo-controlled trial with a crossover design with 41 migraine patients meeting the ICHD-3 (International Classification of Headache Disorders version 3 Beta) Classification criteria